High-level pacidamycin resistance in Pseudomonas aeruginosa is mediated by an opp oligopeptide permease encoded by the opp-fabI operon

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 11, 2013, Pages 5565-5571

  Mistry, Anita ^c   Warren, Mark S ^d   Cusick, John K ^a,e   Karkhoff Schweizer, Roxann R ^a   Lomovskaya, Olga ^b   Schweizer, Herbert P ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b Rempex Pharmaceuticals   (United States)

^c Vifor (International) Inc   (Switzerland)

^d Optivia Biotechnology   (United States)

^e UNIVERSITY OF HAWAII AT HILO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN; LEVOFLOXACIN; OLIGOPEPTIDE; OPPA PROTEIN; OPPB PROTEIN; PACIDAMYCIN; PERIPLASMIC BINDING PROTEIN; PERMEASE; POLYPEPTIDE ANTIBIOTIC AGENT; TETRACYCLINE; UNCLASSIFIED DRUG;

AGED; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; CROSS RESISTANCE; DNA SEQUENCE; DRUG STRUCTURE; GENE FUSION; IN VIVO STUDY; LISTERIA MONOCYTOGENES; MINIMUM INHIBITORY CONCENTRATION; MUTAGENESIS; NONHUMAN; OPERON; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSPOSON;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CARRIER PROTEINS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; LIPOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MUTATION RATE; OPERON; PEPTIDES; PSEUDOMONAS AERUGINOSA; PYRIMIDINE NUCLEOSIDES; URIDINE;

EID: 84885918609     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01198-13     Document Type: Article

References (37)

1. Chen RH, Buko AM, Whittern DN, McAlpine JB. 1989. Pacidamycins, a novel series of antibiotics with anti-Pseudomonas aeruginosa activity. II. Isolation and structural elucidation. J. Antibiot. 42:512-520.
2. Fernandes PB, Swanson RN, Hardy DJ, Hanson CW, Coen L, Rasmussen RR, Chen RH. 1989. Pacidamycins, a novel series of antibiotics with anti-Pseudomonas aeruginosa activity. III. Microbiologic profile. J. Antibiot. 42:521-526.
3. Karwowski JP, Jackson M, Theriault RJ, Chen RH, Barlow GJ, Maus ML. 1989. Pacidamycins, a novel series of antibiotics with anti-Pseudomonas aeruginosa activity. I. Taxonomy of the producing organism and fermentation. J. Antibiot. 42:506-511.
4. Zhang W, Ostash B, Walsh CT. 2010. Identification of the biosynthetic gene cluster for the pacidamycin group of peptidyl nucleoside antibiotics. Proc. Natl. Acad. Sci. U. S. A. 107:16828-16833.
5. Rackham EJ, Gruschow S, Goss RJ. 2011. Revealing the first uridyl peptide antibiotic biosynthetic gene cluster and probing pacidamycin biosynthesis. Bioeng. Bugs 2:218-221.
6. Brandish PE, Kimura KI, Inukai M, Southgate R, Lonsdale JT, Bugg TD. 1996. Modes of action of tunicamycin, liposidomycin B, and mureidomycin A: inhibition of phospho-N-acetylmuramyl-pentapeptide translocase from Escherichia coli. Antimicrob. Agents Chemother. 40: 1640-1644.
7. Mao W, Warren M, Malouin F, Galazzo J, Lee A, Lomovskaya O. 2001. AcrAB-TolC efflux pump contributes to the intrinsic resistance to pacidomycin in Escherichia coli, poster A-35. Abstr. 101st Gen. Meet. Am. Soc. Microbiol.. American Society for Microbiology, Washington, DC.
8. Gotoh N, Murata T, Ozaki T, Kimura T, Kondo A, Nishino T. 2003. Intrinsic resistance of Escherichia coli to mureidomycin A and C due to expression of the multidrug efflux system AcrAB-TolC: comparison with the efflux systems of mureidomycin-susceptible Pseudomonas aeruginosa. J. Infect. Chemother. 9:101-103.
9. Lomovskaya O, Mistry A, Warren M, Lee A. 2001. Characterization of pacidomycin resistant mutants in Pseudomonas aeruginosa, poster A-34. Abstr. Gen. Meet. Am. Soc. Microbiol. American Society for Microbiology, Washington, DC.
10. Watson JM, Holloway BW. 1978. Chromosome mapping in Pseudomonas aeruginosa. J. Bacteriol. 133:1113-1125.
11. Stover CK, Pham X-Q, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FSL, Hufnagle WO, Kowalik DJ, Lagrou M, Garber RL, Goltry L, Tolentino E, Westbrock-Wadman S, Yuan Y, Brody LL, Coulter SN, Folger KR, Kas A, Larbig K, Lim R, Spencer D, WongGK-S, Wu Z, Paulsen IT, Reizer J, Saier MH, Hancock REW, Lory S, Olson MV. 2000. Complete genome sequence of Pseudomonas aeruginosa, an opportunistic pathogen. Nature 406:959-964.
12. Lomovskaya O, Lee A, Hoshino K, Ishida H, Mistry A, Warren MS, Boyer E, Chamberland S, Lee VJ. 1999. Use of a genetic approach to evaluate the consequence of inactivation of efflux pumps in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 43:1340-1346.
13. Held K, Ramage E, Jacobs M, Gallagher L, Manoil C. 2012. Sequenceverified two-allele transposon mutant library for Pseudomonas aeruginosa PAO1. J. Bacteriol. 194:6387-6389.
14. Hoang TT, Karkhoff-Schweizer RR, Kutchma AJ, Schweizer HP. 1998. A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants. Gene 212:77-86.
15. Liss L. 1987. New M13 host: DH5αF' competent cells. Focus 9:13.
16. Schweizer HP. 1994. A method for construction of bacterial hosts for lac-based cloning and expression vectors: α complementation and regulated expression. Biotechniques 17:452-456.
17. Hanahan D. 1983. Studies on transformation of Escherichia coli with plasmids. J. Mol. Biol. 166:557-580.
18. Ohman DE, Cryz SJ, Iglewski BH. 1980. Isolation and characterization of a Pseudomonas aeruginosa PAO mutant that produces altered elastase. J. Bacteriol. 142:836-842.
19. Sambrook J, Russell DW. 2001. Molecular cloning, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
20. Clinical and Laboratory Standards Institute. 2012. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; M07-A9. Approved standard, 9th ed. CLSI, Wayne, PA.
21. Darzins A, Casadaban MJ. 1989. Mini-D3112 bacteriophage transposable elements for genetic analysis of Pseudomonas aeruginosa. J. Bacteriol. 171:3909-3916.
22. Krishnapillai V. 1972. A novel transducing phage. Mol. Gen. Genet. 114: 134-143.
23. Goldbarg JA, Rutenburg AM. 1958. The colorimetric determination of leucine aminopeptidase in urine and serum of normal subjects and patients with cancer and other diseases. Cancer 11:283-291.
24. de Lorenzo V, Timmis KN. 1994. Analysis and construction of stable phenotypes in gram-negative bacteria with Tn5- and Tn10-derived minitransposons. Methods Enzymol. 235:386-405.
25. Jacobs MA, Alwood A, Thaipisuttikul I, Spencer D, Haugen E, Ernst S, Will O, Kaul R, Raymond C, Levy R, Chun-Rong L, Guenthner D, Bovee D, Olson MV, Manoil C. 2003. Comprehensive transposon mutant library of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. U. S. A. 100:14339-14344.
26. Becher A, Schweizer HP. 2000. Integration-proficient Pseudomonas aeruginosa vectors for isolation of single copy chromosomal lacZ and lux gene fusions. Biotechniques 29:948-954.
27. Hoang TT, Kutchma AJ, Becher A, Schweizer HP. 2000. Integration proficient plasmids for Pseudomonas aeruginosa: site-specific integration and use for engineering of reporter and expression strains. Plasmid 43:59-72.
28. Miller JH. 1992. A short course in bacterial genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
29. Poole K, Krebes K, McNally C, Neshat S. 1993. Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J. Bacteriol. 175:7363-7372.
30. Li XZ, Nikaido H, Poole K. 1995. Role of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 39: 1948-1953.
31. Poole K, Srikumar R. 2001. Multidrug efflux in Pseudomonas aeruginosa: components, mechanisms and clinical significance. Curr. Topics Med. Chem. 1:59-71.
32. Lomovskaya O, Warren MS, Lee A, Galazzo J, Fronko R, Lee M, Blais J, Cho D, Chamberland S, Renau T, Leger R, Hecker S, Watkins W, Hoshino K, Ishida H, Lee VJ. 2001. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob. Agents Chemother. 45:105-116.
33. Weinberg MV, Maier RJ. 2007. Peptide transport in Helicobacter pylori: Rokles of Dpp and Opp systems and evidence for additional peptide transporters. J. Bacteriol. 189:3392-3402.
34. Winsor GL, Lam DK, Fleming L, Lo R, Whiteside MD, Yu NY, Hancock RE, Brinkman FS. 2011. Pseudomonas Genome Database: improved comparative analysis and population genomics capability for Pseudomonas genomes. Nucleic Acids Res. 39:D596-D600.
35. Hoang TT, Schweizer HP. 1999. Characterization of the Pseudomonas aeruginosa enoyl-acyl carrier protein reductase: a target for triclosan and its role in acylated homoserine lactone synthesis. J. Bacteriol. 181:5489-5497.
36. Staskawicz B, Panopoulos N. 1980. Phaseolotoxin transport in Escherichia coli and Salmonella typhimurium via the oligopeptide permease. J. Bacteriol. 142:474-479.
37. Borezee E, Pellegrini E, Berche P. 2000. OppA of Listeria monocytogenes, an oligopeptide-binding protein required for bacterial growth at low temperature and involved in intracellular survival. Infect. Immun. 68:7069-7077.